273 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
pleased to report another quarter of strong financial results and we are now actively executing on our investment strategy as evidenced by the recent
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
pleased to report another quarter of strong financial results and we are now actively executing on our investment strategy as evidenced by the recent
8-K
EX-99.1
ln0pa4hvz4ll 4s
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
S-3ASR
ualizrv9xbsi2f
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
4pu 2qpdhxvd74
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
ndslmfo 5o
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
8db18xtfgqyj
21 Jun 22
Regulation FD Disclosure
6:19am
425
kui dzoh3lwmvs
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
ucqiiqgal6pskutkg4hw
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
hrv3dfs06l14
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
54nurwoyvbqz1m3
24 Mar 22
Entry into a Material Definitive Agreement
9:08am